52 research outputs found
169Mobilization of type 1 and type 2 dendritic cells by GM-CSF alone or in combination with G-CSF
Get PDFCirculating tumor cells and bone metastases as detected by FDG–PET/CT in patients with metastatic breast cancer
Get PDFn/
Implementing Changes in Marketing Strategy: The Role of Perceived Outcome-and Process-Oriented Supervisory Actions
Full text linkProtection against experimental echinococcosis by non-specifically stimulated peritoneal cells
No full text133TH1 and TH2 cytokine syntheses by T cells of recipients of G-CSF mobilized allogeneic PBSC
No full textEFFECT OF AZIMEXON THERAPY ON HOST DEFENSE PARAMETERS AND DISEASE-ASSOCIATED SYMPTOMS IN THE ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) AND AIDS-RELATED COMPLEX (ARC)
No full text
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism ?
No full textInternational audienc
Photoreceptors CRYTOCHROME2 and Phytochrome B Control Chromatin Compaction in Arabidopsis1[W][OA]
Get PDFDevelopment and acclimation processes to the environment are associated with large-scale changes in chromatin compaction in Arabidopsis (Arabidopsis thaliana). Here, we studied the effects of light signals on chromatin organization. A decrease in light intensity induces a large-scale reduction in chromatin compaction. This low light response is reversible and shows strong natural genetic variation. Moreover, the degree of chromatin compaction is affected by light quality signals relevant for natural canopy shade. The photoreceptor CRYPTOCHROME2 appears a general positive regulator of low light-induced chromatin decompaction. Phytochrome B also controls light-induced chromatin organization, but its effect appears to be dependent on the genetic background. We present a model in which chromatin compaction is regulated by the light environment via CRYPTOCHROME2 protein abundance, which is controlled by phytochrome B action
A cytokine-based neuroimmunologic mechanism of cancer-related symptoms
No full textInternational audienc
- …
